Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours

Fas Ligand (FasL) expression by cancer cells may contribute to tumour immune escape via the Fas counterattack against tumour-infiltrating lymphocytes (TILs). Whether this plays a role in colorectal carcinogenesis in Lynch syndrome was examined studying FasL expression, tumour cell apoptosis and numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Koornstra, Jan J., de Jong, Steven, Boersma-van Eck, Wietske, Zwart, Nynke, Hollema, Harry, de Vries, Elisabeth G.E., Kleibeuker, Jan H.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2008
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791478/
https://www.ncbi.nlm.nih.gov/pubmed/19067240
http://dx.doi.org/10.1007/s12253-008-9136-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791478/
https://www.ncbi.nlm.nih.gov/pubmed/19067240
http://dx.doi.org/10.1007/s12253-008-9136-7

Ejemplares similares